Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Knapp

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Physiology|December 1, 1994
Progressive alveolar septal injury in primates exposed to 60% oxygen for 14 daysJ D Crapo, G Hayatdavoudi, M J Knapp, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|February 1, 1971
Tissue reaction to intrabony ceramic implantsS N Bhaskar, D E Cutright, M J Knapp, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicityR J Fontana, D K Turgeon, T F Woolf, et al.
JAMA|April 6, 1994
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study GroupM J Knapp, D S Knopman, P R Solomon, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
In vivo interaction of ketoconazole and sucralfate in healthy volunteersP L Carver, R R Berardi, M J Knapp, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1991
Responses of baboons to prolonged hyperoxia: physiology and qualitative pathologyP J Fracica, M J Knapp, C A Piantadosi, et al.
Alzheimer Disease and Associated Disorders|July 3, 1998
Safety of tacrine: clinical trials, treatment IND, and postmarketing experienceS I Gracon, M J Knapp, W G Berghoff, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's diseaseR J Fontana, T M deVries, T F Woolf, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The American Journal of Physiology|December 1, 1994
Progressive alveolar septal injury in primates exposed to 60% oxygen for 14 daysJ D Crapo, G Hayatdavoudi, M J Knapp, et al.
Oral Surgery, Oral Medicine, and Oral Pathology|February 1, 1971
Tissue reaction to intrabony ceramic implantsS N Bhaskar, D E Cutright, M J Knapp, et al.
Hepatology (Baltimore, Md.)|June 1, 1996
The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicityR J Fontana, D K Turgeon, T F Woolf, et al.
JAMA|April 6, 1994
A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study GroupM J Knapp, D S Knopman, P R Solomon, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
In vivo interaction of ketoconazole and sucralfate in healthy volunteersP L Carver, R R Berardi, M J Knapp, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1991
Responses of baboons to prolonged hyperoxia: physiology and qualitative pathologyP J Fracica, M J Knapp, C A Piantadosi, et al.
Alzheimer Disease and Associated Disorders|July 3, 1998
Safety of tacrine: clinical trials, treatment IND, and postmarketing experienceS I Gracon, M J Knapp, W G Berghoff, et al.
British Journal of Clinical Pharmacology|October 9, 1998
Caffeine based measures of CYP1A2 activity correlate with oral clearance of tacrine in patients with Alzheimer's diseaseR J Fontana, T M deVries, T F Woolf, et al.
Pageof 3